Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature.

Yang X, Cao Y, Chen C, Liu L, Wang C, Liu S.

Onco Targets Ther. 2017 Jan 18;10:397-407. doi: 10.2147/OTT.S113736.

2.
3.

Doublecortin-like kinase 1 expression associates with breast cancer with neuroendocrine differentiation.

Liu YH, Tsang JY, Ni YB, Hlaing T, Chan SK, Chan KF, Ko CW, Mujtaba SS, Tse GM.

Oncotarget. 2016 Jan 12;7(2):1464-76. doi: 10.18632/oncotarget.6386.

4.

Fine-needle aspiration detects primary neuroendocrine carcinoma of the breast in a patient with breast implants.

Malowany JI, Kundu U, Santiago L, Krishnamurthy S.

Cytojournal. 2015 Jan 22;12:1. doi: 10.4103/1742-6413.149844.

5.

Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database.

Wang J, Wei B, Albarracin CT, Hu J, Abraham SC, Wu Y.

BMC Cancer. 2014 Mar 4;14:147. doi: 10.1186/1471-2407-14-147.

6.

Search for neuro-endocrine markers (chromogranin A, synaptophysin and VGF) in breast cancers. An integrated approach using immunohistochemistry and gene expression profiling.

Annaratone L, Medico E, Rangel N, Castellano I, Marchiò C, Sapino A, Bussolati G.

Endocr Pathol. 2014 Sep;25(3):219-28. doi: 10.1007/s12022-013-9277-4.

7.

Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature.

Angarita FA, Rodríguez JL, Meek E, Sánchez JO, Tawil M, Torregrosa L.

World J Surg Oncol. 2013 Jun 5;11:128. doi: 10.1186/1477-7819-11-128.

8.

Solid neuroendocrine breast carcinoma: mammographic and sonographic features in thirteen cases.

Wu J, Yang QX, Wu YP, Wang DL, Liu XW, Cui CY, Wang L, Chen Y, Xie CM, Zhang R.

Chin J Cancer. 2012 Nov;31(11):549-56. doi: 10.5732/cjc.011.10370.

9.

Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide.

Yan T, Skaftnesmo KO, Leiss L, Sleire L, Wang J, Li X, Enger PØ.

BMC Cancer. 2011 Dec 20;11:524. doi: 10.1186/1471-2407-11-524.

10.

Arsenic, cadmium and neuron specific enolase (ENO2, γ-enolase) expression in breast cancer.

Soh MA, Garrett SH, Somji S, Dunlevy JR, Zhou XD, Sens MA, Bathula CS, Allen C, Sens DA.

Cancer Cell Int. 2011 Nov 18;11(1):41. doi: 10.1186/1475-2867-11-41.

11.

The extended granin family: structure, function, and biomedical implications.

Bartolomucci A, Possenti R, Mahata SK, Fischer-Colbrie R, Loh YP, Salton SR.

Endocr Rev. 2011 Dec;32(6):755-97. doi: 10.1210/er.2010-0027. Review.

12.

Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis.

Turashvili G, Leung S, Turbin D, Montgomery K, Gilks B, West R, Carrier M, Huntsman D, Aparicio S.

BMC Cancer. 2009 May 29;9:165. doi: 10.1186/1471-2407-9-165.

13.

CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer.

Bergamaschi A, Kim YH, Kwei KA, La Choi Y, Bocanegra M, Langerød A, Han W, Noh DY, Huntsman DG, Jeffrey SS, Børresen-Dale AL, Pollack JR.

Mol Oncol. 2008 Dec;2(4):327-39. doi: 10.1016/j.molonc.2008.09.004.

14.

Supplemental Content

Support Center